Literature DB >> 28320274

Brain Mitochondrial Subproteome of Rpn10-Binding Proteins and Its Changes Induced by the Neurotoxin MPTP and the Neuroprotector Isatin.

A E Medvedev1, O A Buneeva, A T Kopylov, O V Tikhonova, M V Medvedeva, L N Nerobkova, I G Kapitsa, V G Zgoda.   

Abstract

Mitochondria play an important role in molecular mechanisms of neuroplasticity, adaptive changes of the brain that occur in the structure and function of its cells in response to altered physiological conditions or development of pathological disorders. Mitochondria are a crucial target for actions of neurotoxins, causing symptoms of Parkinson's disease in various experimental animal models, and also neuroprotectors. Good evidence exists in the literature that mitochondrial dysfunction induced by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) influences functioning of the ubiquitin-proteasomal system (UPS) responsible for selective proteolytic degradation of proteins from various intracellular compartments (including mitochondria), and neuroprotective effects of certain antiparkinsonian agents (monoamine oxidase inhibitors) may be associated with their effects on UPS. The 19S proteasomal Rpn10 subunit is considered as a ubiquitin receptor responsible for delivery of ubiquitinated proteins to the proteasome proteolytic machinery. In this study, we investigated proteomic profiles of mouse brain mitochondrial Rpn10-binding proteins, brain monoamine oxidase B (MAO B) activity, and their changes induced by a single-dose administration of the neurotoxin MPTP and the neuroprotector isatin. Administration of isatin to mice prevented MPTP-induced inactivation of MAO B and influenced the profile of brain mitochondrial Rpn10-binding proteins, in which two pools of proteins were clearly recognized. The constitutive pool was insensitive to neurotoxic/neuroprotective treatments, while the variable pool was specifically influenced by MPTP and the neuroprotector isatin. Taking into consideration that the neuroprotective dose of isatin used in this study can result in brain isatin concentrations that are proapoptotic for cells in vitro, the altered repertoire of mitochondrial Rpn10-binding proteins may thus represent a part of a switch mechanism from targeted elimination of individual (damaged) proteins to more efficient ("global") elimination of damaged organelles and whole damaged cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28320274     DOI: 10.1134/S0006297917030117

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  6 in total

Review 1.  Tryptophan Metabolites as Mediators of Microbiota-Gut-Brain Communication: Focus on Isatin.

Authors:  Alexei Medvedev; Olga Buneeva
Journal:  Front Behav Neurosci       Date:  2022-06-30       Impact factor: 3.617

2.  The Effect of Neurotoxin MPTP and Neuroprotector Isatin on the Profile of Ubiquitinated Brain Mitochondrial Proteins.

Authors:  Olga Buneeva; Arthur Kopylov; Inga Kapitsa; Elena Ivanova; Victor Zgoda; Alexei Medvedev
Journal:  Cells       Date:  2018-07-31       Impact factor: 6.600

3.  Synthesis and Antiproliferatory Activities Evaluation of Multi-Substituted Isatin Derivatives.

Authors:  Ying Ding; Lianbo Zhao; Ying Fu; Lei Hao; Yupeng Fu; Yuan Yuan; Peng Yu; Yuou Teng
Journal:  Molecules       Date:  2020-12-31       Impact factor: 4.411

Review 4.  Mitochondrial Dysfunction in Parkinson's Disease: Focus on Mitochondrial DNA.

Authors:  Olga Buneeva; Valerii Fedchenko; Arthur Kopylov; Alexei Medvedev
Journal:  Biomedicines       Date:  2020-12-10

Review 5.  Atypical Ubiquitination and Parkinson's Disease.

Authors:  Olga Buneeva; Alexei Medvedev
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

6.  A Neuroprotective Dose of Isatin Causes Multilevel Changes Involving the Brain Proteome: Prospects for Further Research.

Authors:  Alexei Medvedev; Arthur Kopylov; Olga Buneeva; Leonid Kurbatov; Olga Tikhonova; Alexis Ivanov; Victor Zgoda
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.